首页> 美国卫生研究院文献>Case Reports in Medicine >Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
【2h】

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem

机译:西罗莫司洗脱支架的晚期血栓形成:一个多因素问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case of a young patient in whom a sirolimus-eluting stent was implanted on the culprit left anterior descending coronary artery at primary percutaneous coronary intervention (PCI) for acute myocardial infarction. Nine months later she suffered from a reinfarction due to the late stent thrombosis despite a continuous antiplatelet therapy with aspirin and clopidogrel. A cluster of factors that might have contributed to the development of the stent thrombosis were identified: suboptimal PCI technique, complete stent fracture, and clopidogrel resistance. The obstructed stent was successfully reopened by repeat PCI, while the clopidogrel maintenance dosage was doubled to 150 mg daily for the following year. The further long-term clinical course was uneventful.
机译:我们报道了一例年轻患者,其中在急性心肌梗死的一次经皮冠状动脉介入治疗(PCI)时,在西罗莫司洗脱支架上植入了左前降支冠状动脉。九个月后,尽管使用阿司匹林和氯吡格雷持续进行抗血小板治疗,但由于晚期支架血栓形成,她再次发生梗塞。确定了可能导致支架内血栓形成的一系列因素:次优PCI技术,支架完全断裂和氯吡格雷抵抗。通过重复PCI成功地将阻塞的支架重新打开,而第二年的氯吡格雷维持剂量则增加了一倍,达到每天150 mg。进一步的长期临床过程也很顺利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号